A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to ...
After 21 months of investigating and awaiting word from a prosecutor on whether to file charges, Chesterfield County's once ...
The stock is being punished for Entresto’s 50% sales drop, but the quarter still beat on core operating profit thanks to ...
Unless otherwise noted, all growth rates in this Release refer to same period in prior year. 2. Please see detailed guidance ...
The drug from Merck was OK’d for patients with artery-clogging cholesterol that persists even after taking statins.
The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...
Officials under <a href=" Donald Trump want to make it easier for men to get a <a href=" for testosterone, the latest shift ...
HHS Secretary RFK Jr. is announcing updated FDA standards for pasteurized orange juice. Here is what the 10% Brix shift means ...
Comments from FDA and USDA’s 2025 RFI for a UPF definition suggest the main debate is no longer whether UPFs exist, but ...
The Food and Drug Administration has approved a powerful new kind of cholesterol-lowering drug.
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
Most adults have levels of a dangerous type of cholesterol that are above 100, but this new drug can reduce levels to around ...